We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$147B
AUM Growth
+$7.72B
(+5.5%)
Cap. Flow
+$9.48B
Cap. Flow
% of AUM
6.43%
Top 10 Holdings %
Top 10 Hldgs %
41.95%
Holding
4,221
New
328
Increased
2,776
Reduced
891
Closed
131
Avg Time Held Equity + Options
4.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
4
years
Avg Time Held Equity only
4.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$888M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$700M |
| 3 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$408M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$338M |
| 5 |
Vanguard Russell 1000 Value ETF
VONV
|
+$280M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$248M |
| 2 |
Schwab US Large- Cap ETF
SCHX
|
+$41.4M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$39.9M |
| 4 |
Schwab US Large-Cap Value ETF
SCHV
|
+$34.6M |
| 5 |
Schwab US Mid-Cap ETF
SCHM
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 75.77% |
| 2 | Technology | 8.02% |
| 3 | Financials | 3.7% |
| 4 | Industrials | 2.22% |
| 5 | Healthcare | 2.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2651
Evolent Health
EVH
$551M
| $792K | ﹤0.01% |
347,372
+181,158
| +109% | +$575K |
2023 Q4
9 quarters
|
|
2652
Direxion Daily Semiconductor Bull 3X ETF
SOXL
$16.5B
| $790K | ﹤0.01% |
16,497
-13,412
| -45% | -$778K |
2024 Q3
6 quarters
|
|
2653
State Street SPDR Portfolio TIPS ETF
SPIP
$1.04B
| $790K | ﹤0.01% |
30,373
+8,540
| +39% | +$223K |
2021 Q2
19 quarters
|
|
2654
iShares A.I. Innovation and Tech Active ETF
BAI
$13.3B
| $788K | ﹤0.01% |
23,923
+10,164
| +74% | +$349K |
2025 Q3
2 quarters
|
|
2655
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$719M
| $788K | ﹤0.01% |
11,035
+1,732
| +19% | +$122K |
2025 Q3
2 quarters
|
|
2656
ARK Blockchain & Fintech Innovation ETF
ARKF
$912M
| $787K | ﹤0.01% |
20,716
+1,281
| +7% | +$53.8K |
2023 Q3
10 quarters
|
|
2657
iShares iBonds Dec 2028 Term Muni Bond ETF
IBMQ
$684M
| $787K | ﹤0.01% |
30,814
+13,179
| +75% | +$338K |
2025 Q3
2 quarters
|
|
2658
Harrow
HROW
$1.08B
| $785K | ﹤0.01% |
22,273
-2,535
| -10% | -$111K |
2023 Q4
9 quarters
|
|
2659
TCW Transform 500 ETF
VOTE
$1.14B
| $785K | ﹤0.01% |
10,289
-6,531
| -39% | -$521K |
2021 Q4
17 quarters
|
|
2660
US Commodity Index
USCI
$417M
| $784K | ﹤0.01% |
8,226
+1,102
| +15% | +$94.4K |
2024 Q1
8 quarters
|
|
2661
CRA International
CRAI
$1.11B
| $783K | ﹤0.01% |
4,839
+557
| +13% | +$100K |
2023 Q4
9 quarters
|
|
2662
Spyre Therapeutics
SYRE
$7.49B
| $781K | ﹤0.01% |
+15,486
| New | +$584K |
2026 Q1
0 quarters
|
|
2663
State Street Blackstone High Income ETF
HYBL
$565M
| $780K | ﹤0.01% |
28,015
-1,054
| -4% | -$29.7K |
2024 Q4
5 quarters
|
|
2664
Rocket Pharmaceuticals
RCKT
$259M
| $780K | ﹤0.01% |
217,851
+50,812
| +30% | +$202K |
2024 Q4
5 quarters
|
|
2665
Phathom Pharmaceuticals
PHAT
$607M
| $780K | ﹤0.01% |
70,193
-10,573
| -13% | -$134K |
2023 Q1
12 quarters
|
|
2666
Franklin California Municipal Income ETF
FTCA
$538M
| $778K | ﹤0.01% |
106,864
+81,795
| +326% | +$602K |
2025 Q4
1 quarter
|
|
2667
GraniteShares Gold Shares
BAR
$1.36B
| $778K | ﹤0.01% |
16,864
+5,472
| +48% | +$263K |
2024 Q2
7 quarters
|
|
2668
Nuveen Municipal Credit Income Fund
NZF
$2.15B
| $776K | ﹤0.01% |
63,690
-2,340
| -4% | -$29.5K |
2015 Q3
42 quarters
|
|
2669
GameStop
GME
$14.1B
| $775K | ﹤0.01% |
33,635
+17,787
| +112% | +$413K |
2024 Q2
7 quarters
|
|
2670
Cathay General Bancorp
CATY
$4.01B
| $773K | ﹤0.01% |
15,510
+248
| +2% | +$12.5K |
2023 Q2
11 quarters
|
|
2671
Perella Weinberg Partners
PWP
$1.02B
| $773K | ﹤0.01% |
42,580
+663
| +2% | +$13K |
2024 Q4
5 quarters
|
|
2672
Xeris Biopharma Holdings
XERS
$1.84B
| $773K | ﹤0.01% |
133,285
+16,747
| +14% | +$111K |
2024 Q1
8 quarters
|
|
2673
iShares US Oil & Gas Exploration & Production ETF
IEO
$835M
| $773K | ﹤0.01% |
6,187
+25
| +0.4% | +$2.65K |
2020 Q4
21 quarters
|
|
2674
Community Healthcare Trust
CHCT
$380M
| $773K | ﹤0.01% |
48,621
+153
| +0.3% | +$2.58K |
2025 Q2
3 quarters
|
|
2675
Skydance Corporation
SKYD
$36.6B
| $772K | ﹤0.01% |
171,120
-54,102
| -24% | -$296K |
2025 Q3
2 quarters
|
|
Similar funds
Creative Planning's Q1 2026 Portfolio in Review
As of Q1 2026, Creative Planning held 4,221 positions worth $147B, up 5.5% from $140B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $9.48B of net new capital in Q1 2026, opening 328 new positions and adding to 2,776 existing holdings. Its largest new stake was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 76% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $248M trimmed.
- Creative Planning's largest Q1 2026 buy was Innovator US Equity Power Buffer ETF August: 270,134 shares worth $11.5M.
- Creative Planning added most to Vanguard Short-Term Bond ETF in Q1 2026, an estimated $888M increase.
- Creative Planning's biggest Q1 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $248M.
- Creative Planning fully exited CyberArk in Q1 2026, selling an estimated $9.29M.
- Creative Planning's ten largest holdings make up 42% of its $147B portfolio in Q1 2026.
- Creative Planning opened 328 new positions and closed 131 in Q1 2026.
- Creative Planning's portfolio value rose 5.5% quarter-over-quarter to $147B.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.